Moreover, Li D. et al. found NF-kappaB activation seems to play a critical role in the regulation of AngII receptors, which provide a basis for the use of antioxidants and AT1R blockers in designing therapy of atherosclerosis [28]. Here, AGTR1 is linked to atherosclerosis.